The dynamic biliary epithelia: molecules, pathways, and disease.
about
Biology of Cholangiocytes: From Bench to BedsideThe enteric microbiome in hepatobiliary health and diseaseMicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentNuclear Factor, Erythroid 2-Like 2 Regulates Expression of Type 3 Inositol 1,4,5-Trisphosphate Receptor and Calcium Signaling in Cholangiocytes.Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography.Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapiesDirected differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells.The roles of Toll-like receptor 4 in the pathogenesis of pathogen-associated biliary fibrosis caused by Clonorchis sinensis.Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitisCharacterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitisAssociation between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis.Schistosome and liver fluke derived catechol-estrogens and helminth associated cancersA comprehensive analysis of aquaporin and secretory related gene expression in neonate and adult cholangiocytes.Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome.Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes.Functional and structural features of cholangiocytes in health and disease.The Cholangiopathies.The Microbiome and Immune Regulation After Transplantation.Role of the Intestinal Microbiome in Cholestatic Liver Disease.Why does infection with some helminths cause cancer?Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review.Mechanisms of tissue injury in autoimmune liver diseases.Portal Fibroblasts in Biliary FibrosisPrimary biliary cirrhosis: safety and benefits of established and emerging therapies.Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.Starring role of toll-like receptor-4 activation in the gut-liver axis.Emerging pharmacologic therapies for primary sclerosing cholangitis.Bromodomain and extraterminal (BET) proteins regulate biliary-driven liver regeneration.Expression of mediators of purinergic signaling in human liver cell lines.Liver fluke infection and cholangiocarcinoma: a review.Emerging advancements in liver regeneration and organogenesis as tools for liver replacement.Regenerative Medicine and the Biliary Tree.Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis.Pathobiology of biliary epithelia.Isolation and characterization of hepatic mast cells from cholestatic rats.Role of the microbiota and antibiotics in primary sclerosing cholangitis.Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease.Aquaporins and Gland Secretion.Directed differentiation of cholangiocytes from human pluripotent stem cells.
P2860
Q26738866-68E35ED8-BA58-41AE-8BB1-DDF81DF2DD2CQ26777426-A7BED09F-6E59-461A-B5B1-5A3090B61EA2Q26783579-BD7BE5C5-5619-491D-BDD7-986694310AD0Q27333570-D7FEE0BB-E2E0-45B3-A849-3D302F7D728AQ30560951-D681C0DD-8E82-4DD5-913B-67CF422C5D02Q31170968-CD44F4C7-4805-4864-BA17-1D9054512E8BQ33787914-80C0B2D9-D7DC-438B-A214-581E59BCF26FQ33818842-8B9FC787-81FE-45B7-B8BF-7ED42AA6AA57Q34206508-5E64244F-6C85-4E0C-AA8E-638D0DD8878DQ34287861-83A7E9E0-71E4-45D2-B401-D6E8A56D525DQ34416616-AC909B55-2399-4A59-A39D-77B3ADFC3752Q34763466-C59187E7-89FD-4D4C-88A0-3B72C601FBF0Q34812442-2B268A8E-6646-466E-AB3E-642A023CA5B8Q34909875-0324524C-32EF-4C7A-8E3A-01FE76EB96D9Q35661071-ECA02882-1D32-4835-9CCD-D82A107B4474Q35933236-E1919C18-0174-4C0F-B159-A062C1A7395AQ35942610-BD1D42CE-E695-47D4-8404-F67D317F8107Q36102645-8FBAA553-DE22-46CF-A7BB-05D286FD37FBQ36294233-642FD685-3F88-4C28-89C3-15986EEC64D3Q36310498-2BDC8968-9643-4BE2-8242-421A1A5452EEQ38211812-E599AEC9-CB50-4725-A13B-528A8D1B491DQ38235918-501A0BBA-7B8A-4A3C-AC43-F92A69E91925Q38322997-2E27E0FF-0607-4B0D-98C5-734E6E541634Q38554677-C62C947F-46BB-4EDF-BBDD-E9F0A8A8BB11Q38596985-FAC12D23-1BC6-44DF-95F5-40F0627AB89FQ38645789-47DAD258-36EC-424C-B787-5F56AEE56BF8Q38751076-7EEF92D5-B1B2-44BF-99E0-4A59AE46396EQ38824596-FCBE5F8E-958C-455D-B3D5-2D8039C4E061Q38959199-ADA2D4D6-B647-46B7-BC77-80CF760C7246Q38975511-A1DB2356-D584-4FF1-BBC7-DAA07CE09670Q38984235-4D00195F-776B-4FF2-ABAC-517A67483868Q39136966-1F27456D-3C03-4C98-8148-C2009092DEF8Q39177947-99829C21-7B20-471B-9FD1-1E95C7FF2FBCQ39440062-29F789E0-A995-4C17-9471-44B9508514D8Q41576573-D5E0F6CE-26F3-48BA-B13D-599B30D2E8C6Q42174395-A756164F-DA8C-49A3-8BD9-E972A4230D11Q50142593-22C60C76-2545-4095-9726-D9DD69B71EA5Q51064713-7DC52C5C-9CBB-43C3-8DE8-5017DF001E6CQ51112312-439B2E29-4130-4D07-89A3-D0C77B825B82Q52931552-2EDBFFB8-5633-46F7-8E7F-F0CF20BF5C38
P2860
The dynamic biliary epithelia: molecules, pathways, and disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The dynamic biliary epithelia: molecules, pathways, and disease.
@en
The dynamic biliary epithelia: molecules, pathways, and disease.
@nl
type
label
The dynamic biliary epithelia: molecules, pathways, and disease.
@en
The dynamic biliary epithelia: molecules, pathways, and disease.
@nl
prefLabel
The dynamic biliary epithelia: molecules, pathways, and disease.
@en
The dynamic biliary epithelia: molecules, pathways, and disease.
@nl
P2093
P2860
P1476
The dynamic biliary epithelia: molecules, pathways, and disease.
@en
P2093
James H Tabibian
Nicholas F LaRusso
Patrick L Splinter
Steven P O'Hara
P2860
P304
P356
10.1016/J.JHEP.2012.10.011
P577
2012-10-17T00:00:00Z